Adhesive preparation containing bisoprolol
Inventors
ABE, Eriko • Tachikawa, Yu • Ameyama, Satoshi • Urushihara, Naoko • Ishikura, Jun • Nakamura, Tetsuya • Yokouchi, Akira • Inoue, Yoshitaka • Aoyagi, Kazuhiro • Tanaka, Tomoya • NISHIDA, Naohiro • Minami, Kunihiro
Assignees
Interested in licensing this patent?
MTEC can help explore whether this patent might be available for licensing for your application.
Abstract
An adhesive preparation containing bisoprolol includes a backing and a pressure-sensitive adhesive layer formed on one side of the backing. The pressure-sensitive adhesive layer contains a polymer prepared through copolymerization of monomer components including a hydroxyl group-containing monomer and an alkyl (meth)acrylate monomer (component (A)), a polymer prepared through copolymerization of monomer components including a methyl methacrylate monomer and a butyl methacrylate monomer (component (B)), and bisoprolol (component (C)).
Core Innovation
The invention provides an adhesive preparation containing bisoprolol, comprising a backing and a pressure-sensitive adhesive layer formed on one side of the backing. The pressure-sensitive adhesive layer contains component (A) to component (C), where component (A) is a polymer prepared through copolymerization including a hydroxyl group-containing monomer, an alkyl (meth)acrylate monomer, and N-vinyl-cyclic amide monomer, component (B) is a polymer prepared through copolymerization including a methyl methacrylate monomer and a butyl methacrylate monomer, and component (C) is bisoprolol.
The invention addresses improved long-term skin adhesion while maintaining adhesive properties even with substantial organic liquid. It further targets high bisoprolol dermal permeability in the transdermal adhesive context while preserving pressure-sensitive adhesive layer performance.
The adhesive formulation balances cohesive property, adhesive force/holding power, and skin permeation based on performance comparisons reported in the disclosure. The components are defined by the selection of hydroxyl group-containing monomer structures in component (A) and by the composition and polymerization-derived characteristics of components (A) and (B), with bisoprolol included as component (C).
Documented preparation and evaluation include representative polymer syntheses and adhesive preparation examples, together with Table 1–Table 2 performance outcomes. The reported results indicate improved cohesive property, adhesive force/holding power, and skin permeation versus comparative formulations within the disclosed bisoprolol-containing transdermal pressure-sensitive adhesive system.
Claims Coverage
The independent claims identify a bisoprolol-containing pressure-sensitive adhesive layer on a backing, with the adhesive layer defined by three components (A) to (C) that are prepared via copolymerization and combined with bisoprolol. The dependent claims further refine the formulation through quantitative component ratios, inclusion of an organic liquid component, specification of the hydroxyl group-containing monomer, and polymer molecular-weight constraints.
Bisoprolol-containing pressure-sensitive adhesive layer on a backing
An adhesive preparation containing bisoprolol, comprising a backing and a pressure-sensitive adhesive layer formed on one side of the backing; the pressure-sensitive adhesive layer contains component (A) to component (C) including component (C) as bisoprolol.
Hydroxyl group-containing monomer-based copolymer as component (A)
Component (A): a polymer prepared through copolymerization of monomer components including a hydroxyl group-containing monomer, an alkyl (meth)acrylate monomer, and N-vinyl-cyclic amide monomer.
Methyl methacrylate/butyl methacrylate copolymer as component (B)
Component (B): a polymer prepared through copolymerization of monomer components including a methyl methacrylate monomer and a butyl methacrylate monomer.
Organic liquid component in the pressure-sensitive adhesive layer
The pressure-sensitive adhesive preparation containing bisoprolol further includes an organic liquid component in the pressure-sensitive adhesive layer.
N-hydroxyalkyl(meth)acrylamide as the hydroxyl group-containing monomer
The adhesive preparation containing bisoprolol specifies that the hydroxyl group-containing monomer is N-hydroxyalkyl(meth)acrylamide.
Defined component (A)/(B) weight ratio
The weight ratio of component (A) to component (B) is from 1/0.05 to 1/1 by weight.
Polymer weight-average molecular weight ranges for components (A) and (B)
Component (A) and component (B) are further defined with specific weight-average molecular weight constraints, including component (A) in a range and component (B) in a range of 100,000 to 200,000 for the polymer of component (B).
Across the claimed coverage, the core inventive system is the combination of bisoprolol (component (C)) with a pressure-sensitive adhesive layer defined by two copolymer components (A) and (B) prepared through specified copolymerization feed components. Dependent refinements constrain the formulation by adding an organic liquid component, specifying the hydroxyl group-containing monomer as N-hydroxyalkyl(meth)acrylamide, imposing a component (A)/(B) by-weight ratio range, and applying polymer molecular-weight constraints.
Stated Advantages
Improved long-term skin adhesion.
High bisoprolol dermal permeability.
Maintained adhesive properties even with substantial organic liquid.
Improved cohesive property.
Improved adhesive force/holding power.
Improved skin permeation versus comparative formulations.
Documented Applications
Transdermal pressure-sensitive adhesive using a bisoprolol-containing pressure-sensitive adhesive layer on a backing for skin/permeation testing.
Interested in licensing this patent?